Pharmaceutical IP and competition law in South Africa: overview
Pharmaceutical IP and competition law in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie
A Q&A guide to pharmaceutical IP and competition law in South Africa.
The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.
To read the full Q&A, visit Thomson Reuters Practical Law.
For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit Medicinal product regulation and product liability in South Africa: overview.
Trade Mark Registration: The Finish Line Is Worth the Wait
Starting a business is exciting. Whether you are opening a restaurant, launching a clothing label, developing an app or offering professional services, the goal is usually the same: to build something...
September 17 2026
Track-and-trace measures target illicit goods
South Africa is stepping up cooperation between the South African Revenue Service (SARS) and the National Consumer Commission (NCC) to combat illicit goods. The two authorities signed a Memorandum of ...
September 15 2026
Turning locally developed IP into battery-sector opportunities
South Africa is seeking to strengthen its position in the global electric mobility and battery value chains by supporting the development and commercialisation of locally developed technologies and in...
September 15 2026